Non-Invasive Chromosomal Evaluation of 22q11.2

NCT02541058 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 420

Last updated 2020-04-30

No results posted yet for this study

Summary

This study is being conducted to develop and evaluate a cell-free fetal DNA test (Harmony) for non-invasive prenatal detection of 22q11.2 chromosomal deletion or duplication.

Conditions

  • 22q.11.2 Deletion/Duplication

Sponsors & Collaborators

  • Cindy Cisneros

    lead INDUSTRY

Principal Investigators

  • Frank Ong, MD · Roche Sequencing Solutions

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2020-03-17
Completion
2020-03-17

Countries

  • Belgium

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02541058 on ClinicalTrials.gov